
Mass General Cancer Center
@MGHCancerCenter
Followers
9K
Following
3K
Media
4K
Statuses
8K
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham. Make an appt: 617-724-4000 | https://t.co/rWLqZauBGm
Joined July 2009
Today I had so much fun to run 5K alongside my friends and colleagues at @MGHCancerCenter @MGHBreastOnc @MGBResearchNews. We run together for one goal that is to conquer cancer.
0
3
5
Amazing☀️ day to run 5K for MGB @MGHCancerCenter with family friends colleagues & @DAVIDPRYANMD 🏃♂️🏃♀️🏃♂️🏃♀️ along the beautiful #CharlesRiver no less‼️ For our patients🫶 Team #radonc And our own health ! 27:50min not bad, all that workout paid off💪😅
2
3
18
Beautiful day for the Mass General Brigham Eversource Cancer 5K Run-Walk to support Brian’s Fund and cancer care! Thanks to all our participants and donors! @MGHCancerCenter @BryanDChoi @ShankarLabMGH @MGBneurosurgery
0
4
9
Glad to see the lay press spreading the news that cancer is becoming a chronic disease! Way to go Dr Jessica Lin @MGHCancerCenter
wsj.com
Stage-four cancer patients are living longer, challenging the idea of what it means to have and survive cancer. “The science just needs to stay a step ahead of me.”
1
5
28
Colorectal cancer is on the rise among younger adults. Aparna Parikh, MD, medical director of the Center for Young Adult Colorectal Cancer, discusses ways individuals can reduce their risk of colon cancer. Learn more:
1
1
0
Registration is open for the 2025 Mass General Brigham Eversource Cancer 5k Run-Walk! Join us on Sunday, September 14 for an inspiring morning along the Charles River Esplanade. Choose from a 5k run, 5k walk or 100-yard kids’ dash and enjoy family-friendly activities,
2
3
4
A Mass General Brigham study identifies ways to lower the risk of liver cancer for patients with Hepatitis B infection.
0
1
3
It was amazing today to visit the @MGHCancerCenter to meet with Dr. Choi and Dr. Grewal and to walk through the labs that are the recipient of A Shot For Life funding! We certainly know this as an organization, but we hope that all in our community are aware of just how
0
6
29
An #OpenAccess review in @Cancer_Cell on circulating tumor cells (CTCs) from the prolific @MGHCancerCenter group: Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications https://t.co/deSvkFABR7
cell.com
Circulating tumor cells (CTCs) are cancer cells shed into the bloodstream. While their utility has been limited by challenges in rare cell capture, recent technological advances could enhance the...
0
10
47
Lynn Gray-Meltzer, PT, DPT, and Steve Wechsler, PT, DPT, PhD, share their insights on the benefits of exercise during cancer treatment. https://t.co/lAXitQeIkf
0
0
0
We are pleased to share that Mass General, a founding member of @MassGenBrigham, has been recognized as one of the nation’s top five best cancer hospitals by @usnews. A big thank you to all our physicians, nurses and staff! https://t.co/RM9ZHcC1Qc
1
6
8
No Monday blues at @MGBforChildren today! @MtJoyBand performed a mini concert for our pediatric patients, their families and our staff. The room was packed with good vibes and great energy. Thanks to @FamilyReach for helping make this special visit to @mghcancercenter possible.
4
5
12
Matthew Frigault, MD, inaugural incumbent of the John and Ashley Ranelli Endowed Scholar in Cancer Innovation at Massachusetts General Hospital, shares the innovative way cellular therapies work, and how we are uniquely positioned as an integrated system to lead the discovery and
0
2
6
We analyzed long term outcomes of cystic vs solid PanNETs. Low LN met and recurrence rate, with favourable survival for cystic PanNETs regardless of tumor size (</> 3 cm) support LN/parenchyma sparing operations, and observation in high risk surgical patients. @AnnalsofSurgery
1
5
26
A recent paper published in Cell Reports Medicine, referred to as, “Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants,” authored by Or-Yam Revach, PhD, a postdoctoral research fellow, and Russell W. Jenkins, MD, PhD, a physician-investigator in the
2
1
0
The Campaign for Mass General fueled breakthroughs in CAR T-cell therapy, offering new hope to patients with challenging cancers like glioblastoma, a rare and aggressive brain cancer. Community fundraisers like Mike Slonina’s A Shot for Life contribute to this revolutionary
0
2
4
👥 Connect, learn, & collaborate with your peers! Join Dr. Smith, Dr. Gao, @CaPsurvivorship, @davidjeinstein, @RickLee6 & @VincentWenxinXu at the Genitourinary Cancers State of the Science Summit on July 22! Register today: https://t.co/xh0KDqCowe
@MGHCancerCenter #SOSSconnects
0
5
9
Congratulations to Iris Gibbs, MD, FASTRO; Helen Shih, MD, MS, MPH, FASTRO; & Joachim Yahalom, MD, FASTRO on their 2025 ASTRO Mentorship awards!! They will be recognized at #ASTRO25 in San Francisco. @StanfordRadOnc @MassGeneralNews @MSK_RadOnc
https://t.co/TIGyGv8Zfq
1
13
48
In a new study, researchers from @MGHCancerCenter and colleagues identified ways to lower risk of liver cancer for people with HBV. The study was published in @NatureComms. Read more: https://t.co/DP0AvNTYjP
https://t.co/YWiqSw2I2n
@CaImmunoprevent
0
4
6
Inspired by his mother’s experience at the Mass General Cancer Center, Mike Slonina founded A Shot for Life (ASFL), a sport based non-profit organization that supports cancer research initiatives. Funds raised by ASFL contribute to pioneering efforts in glioblastoma treatment, a
0
0
0